Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

Epithelial Mutations in Endometriosis: Link to Ovarian Cancer.

Bulun SE, Wan Y, Matei D.

Endocrinology. 2019 Jan 17. doi: 10.1210/en.2018-00794. [Epub ahead of print]

PMID:
30657901
2.

The Influence of Physical Exercise on Smoking Patients with Peripheral Arterial Disease.

Patru S, Marcu IR, Matei D, Bighea AC.

Curr Health Sci J. 2018 Jan-Mar;44(1):34-38. doi: 10.12865/CHSJ.44.01.06. Epub 2018 Mar 23.

3.

Targeting Cancer Stemness in the Clinic: From Hype to Hope.

Saygin C, Matei D, Majeti R, Reizes O, Lathia JD.

Cell Stem Cell. 2019 Jan 3;24(1):25-40. doi: 10.1016/j.stem.2018.11.017. Epub 2018 Dec 27. Review.

PMID:
30595497
4.

Updates on adjuvant chemotherapy and radiation therapy for endometrial cancer.

Cowan M, Strauss JB, Barber EL, Matei D.

Curr Opin Obstet Gynecol. 2019 Feb;31(1):31-37. doi: 10.1097/GCO.0000000000000506.

PMID:
30571659
5.

Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies: Time to Improve Radiologists' Training Program?

Luzzago S, Petralia G, Musi G, Catellani M, Alessi S, Di Trapani E, Mistretta FA, Serino A, Conti A, Pricolo P, Nazzani S, Mirone V, Matei DV, Montanari E, de Cobelli O.

Clin Genitourin Cancer. 2018 Oct 23. pii: S1558-7673(18)30554-8. doi: 10.1016/j.clgc.2018.10.006. [Epub ahead of print]

PMID:
30527286
6.

Pembrolizumab in patients with programmed death ligand 1-positive advanced ovarian cancer: Analysis of KEYNOTE-028.

Varga A, Piha-Paul S, Ott PA, Mehnert JM, Berton-Rigaud D, Morosky A, Yang P, Ruman J, Matei D.

Gynecol Oncol. 2018 Dec 3. pii: S0090-8258(18)31418-5. doi: 10.1016/j.ygyno.2018.11.017. [Epub ahead of print]

PMID:
30522700
7.

Predictors of Residual T1 High Grade on Re-Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder Cancer.

Ferro M, Di Lorenzo G, Buonerba C, Lucarelli G, Russo GI, Cantiello F, Farhan ARA, Di Stasi S, Musi G, Hurle R, Vincenzo S, Busetto GM, De Berardinis E, Perdonà S, Borghesi M, Schiavina R, Almeida GL, Bove P, Lima E, Grimaldi G, Matei DV, Mistretta FA, Crisan N, Terracciano D, Paolo V, Battaglia M, Guazzoni G, Autorino R, Morgia G, Damiano R, Muto M, Rocca R, Mirone V, de Cobelli O, Vartolomei MD.

J Cancer. 2018 Oct 20;9(22):4250-4254. doi: 10.7150/jca.26129. eCollection 2018.

8.

IL-6 mediates platinum-induced enrichment of ovarian cancer stem cells.

Wang Y, Zong X, Mitra S, Mitra AK, Matei D, Nephew KP.

JCI Insight. 2018 Dec 6;3(23). pii: 122360. doi: 10.1172/jci.insight.122360. [Epub ahead of print]

9.

Neutrophil, Platelets, and Eosinophil to Lymphocyte Ratios Predict Gleason Score Upgrading in Low-Risk Prostate Cancer Patients.

Ferro M, Musi G, Serino A, Cozzi G, Mistretta FA, Costa B, Bianchi R, Cordima G, Luzzago S, Di Trapani E, Tagliabue E, Vartolomei MD, Terracciano D, Cassatella MC, Salvatici M, Conti A, Sandri MT, Cioffi A, Turetti M, Catellani M, Bottero D, Matei DV, Mirone V, de Cobelli O.

Urol Int. 2019;102(1):43-50. doi: 10.1159/000494259. Epub 2018 Nov 8.

PMID:
30408799
10.

siRNA Delivery Using Dithiocarbamate-Anchored Oligonucleotides on Gold Nanorods.

Wang J, Thomas M, Lin P, Cheng JX, Matei DE, Wei A.

Bioconjug Chem. 2018 Nov 15. doi: 10.1021/acs.bioconjchem.8b00723. [Epub ahead of print]

PMID:
30395447
11.

Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy.

Friedlander M, Matulonis U, Gourley C, du Bois A, Vergote I, Rustin G, Scott C, Meier W, Shapira-Frommer R, Safra T, Matei D, Shirinkin V, Selle F, Fielding A, Lowe ES, McMurtry EL, Spencer S, Rowe P, Mann H, Parry D, Ledermann J.

Br J Cancer. 2018 Oct;119(9):1075-1085. doi: 10.1038/s41416-018-0271-y. Epub 2018 Oct 24.

PMID:
30353045
12.

Targeting the Microenvironment in High Grade Serous Ovarian Cancer.

Nwani NG, Sima LE, Nieves-Neira W, Matei D.

Cancers (Basel). 2018 Aug 10;10(8). pii: E266. doi: 10.3390/cancers10080266. Review.

13.

An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer.

Ferro M, Vartolomei MD, Russo GI, Cantiello F, Farhan ARA, Terracciano D, Cimmino A, Di Stasi S, Musi G, Hurle R, Serretta V, Busetto GM, De Berardinis E, Cioffi A, Perdonà S, Borghesi M, Schiavina R, Cozzi G, Almeida GL, Bove P, Lima E, Grimaldi G, Matei DV, Crisan N, Muto M, Verze P, Battaglia M, Guazzoni G, Autorino R, Morgia G, Damiano R, de Cobelli O, Shariat S, Mirone V, Lucarelli G.

World J Urol. 2018 Jul 10. doi: 10.1007/s00345-018-2397-1. [Epub ahead of print]

PMID:
29992381
14.

Dual Combined Laparoscopic Approach for Renal-Cell Carcinoma with Renal Vein and Level I-II Inferior Vena Cava Thrombus: Our Technique and Initial Results.

Crisan N, Andras I, Grad DL, Telecan T, Coman RT, de Cobelli O, Matei DV, Coman I.

J Endourol. 2018 Sep 12;32(9):837-842. doi: 10.1089/end.2018.0228. Epub 2018 Aug 3.

PMID:
29947249
15.

Hormonal strategies in gynecologic cancer: Bridging biology and therapy.

Nieves-Neira W, Kim JJ, Matei D.

Gynecol Oncol. 2018 Aug;150(2):207-210. doi: 10.1016/j.ygyno.2018.06.005. Epub 2018 Jun 20. No abstract available.

PMID:
29933928
16.

Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol.

Luzzago S, Musi G, Catellani M, Russo A, Di Trapani E, Mistretta FA, Bianchi R, Cozzi G, Conti A, Pricolo P, Ferro M, Matei DV, Mirone V, Petralia G, de Cobelli O.

Urol Int. 2018;101(1):56-64. doi: 10.1159/000488772. Epub 2018 May 7.

PMID:
29734177
17.

Meta-analysis of studies comparing oncologic outcomes of radical prostatectomy and brachytherapy for localized prostate cancer.

Cozzi G, Musi G, Bianchi R, Bottero D, Brescia A, Cioffi A, Cordima G, Delor M, Di Trapani E, Ferro M, Matei DV, Russo A, Mistretta FA, De Cobelli O.

Ther Adv Urol. 2017 Oct 9;9(11):241-250. doi: 10.1177/1756287217731449. eCollection 2017 Nov.

18.

An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations.

Pulliam N, Fang F, Ozes AR, Tang J, Adewuyi A, Keer H, Lyons J, Baylin SB, Matei D, Nakshatri H, Rassool FV, Miller KD, Nephew KP.

Clin Cancer Res. 2018 Jul 1;24(13):3163-3175. doi: 10.1158/1078-0432.CCR-18-0204. Epub 2018 Apr 3.

PMID:
29615458
19.

Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity.

Özeş AR, Pulliam N, Ertosun MG, Yılmaz Ö, Tang J, Çopuroğlu E, Matei D, Özeş ON, Nephew KP.

Oncogene. 2018 Jun;37(26):3589-3600. doi: 10.1038/s41388-018-0218-z. Epub 2018 Mar 26.

20.

Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor Niche.

Condello S, Sima L, Ivan C, Cardenas H, Schiltz G, Mishra RK, Matei D.

Cancer Res. 2018 Jun 1;78(11):2990-3001. doi: 10.1158/0008-5472.CAN-17-2319. Epub 2018 Mar 6.

21.

A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses.

Matei D, Ghamande S, Roman L, Alvarez Secord A, Nemunaitis J, Markham MJ, Nephew KP, Jueliger S, Oganesian A, Naim S, Su XY, Keer H, Azab M, Fleming GF.

Clin Cancer Res. 2018 May 15;24(10):2285-2293. doi: 10.1158/1078-0432.CCR-17-3055. Epub 2018 Mar 2.

PMID:
29500276
22.

CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells.

Oleinika K, Rosser EC, Matei DE, Nistala K, Bosma A, Drozdov I, Mauri C.

Nat Commun. 2018 Feb 15;9(1):684. doi: 10.1038/s41467-018-02911-y.

23.

Outcomes of robotic-assisted radical prostatectomy for patients in two extreme age-groups (< 50 years vs > 65 years).

Coman RT, Crisan N, Andras I, Bud G, Matei DV, DE Cobelli O, Coman I, Bocsan IS.

Clujul Med. 2018;91(1):92-97. doi: 10.15386/cjmed-825. Epub 2018 Jan 15.

24.

Thulium Laser Treatment of Upper Urinary Tract Carcinoma: A Multi-Institutional Analysis of Surgical and Oncological Outcomes.

Musi G, Mistretta FA, Marenghi C, Russo A, Catellani M, Nazzani S, Conti A, Luzzago S, Ferro M, Matei DV, Carmignani L, de Cobelli O.

J Endourol. 2018 Mar;32(3):257-263. doi: 10.1089/end.2017.0915. Epub 2018 Feb 21.

PMID:
29357686
25.

Ultrastable Silicon Cavity in a Continuously Operating Closed-Cycle Cryostat at 4 K.

Zhang W, Robinson JM, Sonderhouse L, Oelker E, Benko C, Hall JL, Legero T, Matei DG, Riehle F, Sterr U, Ye J.

Phys Rev Lett. 2017 Dec 15;119(24):243601. doi: 10.1103/PhysRevLett.119.243601. Epub 2017 Dec 15.

PMID:
29286721
26.

Genomic and Epigenomic Signatures in Ovarian Cancer Associated with Resensitization to Platinum Drugs.

Fang F, Cardenas H, Huang H, Jiang G, Perkins SM, Zhang C, Keer HN, Liu Y, Nephew KP, Matei D.

Cancer Res. 2018 Feb 1;78(3):631-644. doi: 10.1158/0008-5472.CAN-17-1492. Epub 2017 Dec 11.

PMID:
29229600
27.

Thulium-yttrium-aluminium-garnet (Tm:YAG) laser treatment of penile cancer: oncological results, functional outcomes, and quality of life.

Musi G, Russo A, Conti A, Mistretta FA, Di Trapani E, Luzzago S, Bianchi R, Renne G, Ramoni S, Ferro M, Matei DV, Cusini M, Carmignani L, de Cobelli O.

World J Urol. 2018 Feb;36(2):265-270. doi: 10.1007/s00345-017-2144-z. Epub 2017 Dec 2.

PMID:
29197968
28.

Robot-assisted Partial Nephrectomy: 5-yr Oncological Outcomes at a Single European Tertiary Cancer Center.

Vartolomei MD, Matei DV, Renne G, Tringali VM, Crisan N, Musi G, Mistretta FA, Russo A, Cozzi G, Cordima G, Luzzago S, Cioffi A, Di Trapani E, Catellani M, Delor M, Bottero D, Imbimbo C, Mirone V, Ferro M, de Cobelli O.

Eur Urol Focus. 2017 Oct 27. pii: S2405-4569(17)30242-0. doi: 10.1016/j.euf.2017.10.005. [Epub ahead of print]

PMID:
29111154
29.

Linear and nonlinear parameters of heart rate variability in ischemic stroke patients.

Constantinescu V, Matei D, Costache V, Cuciureanu D, Arsenescu-Georgescu C.

Neurol Neurochir Pol. 2018 Mar;52(2):194-206. doi: 10.1016/j.pjnns.2017.10.002. Epub 2017 Oct 11.

PMID:
29110883
30.

Effects of biofeedback versus switch-triggered functional electrical stimulation on sciatica-related foot drop.

Sardaru DP, Matei D, Zaharia-Kezdi D, Pendefunda L.

J Back Musculoskelet Rehabil. 2018;31(2):239-245. doi: 10.3233/BMR-169578.

PMID:
28946515
31.

Cytokines Genotype-Phenotype Correlation in Nonalcoholic Steatohepatitis.

Bocsan IC, Milaciu MV, Pop RM, Vesa SC, Ciumarnean L, Matei DM, Buzoianu AD.

Oxid Med Cell Longev. 2017;2017:4297206. doi: 10.1155/2017/4297206. Epub 2017 Aug 9.

32.

Serum metabolomics can predict the outcome of first systematic transrectal prostate biopsy in patients with PSA <10 ng/ml.

Andras I, Crisan N, Vesa S, Rahota R, Romanciuc F, Lazar A, Socaciu C, Matei DV, de Cobelli O, Bocsan IS, Coman RT.

Future Oncol. 2017 Aug;13(20):1793-1800. doi: 10.2217/fon-2017-0078. Epub 2017 Aug 4.

PMID:
28776421
33.

Robot-Assisted Vesico-Vaginal Fistula Repair: Our Technique and Review of the Literature.

Matei DV, Zanagnolo V, Vartolomei MD, Crisan N, Ferro M, Bocciolone L, Maggioni A, Coman I, de Cobelli O.

Urol Int. 2017;99(2):137-142. doi: 10.1159/000475887. Epub 2017 Jul 26. Review.

PMID:
28743109
34.

1.5  μm Lasers with Sub-10 mHz Linewidth.

Matei DG, Legero T, Häfner S, Grebing C, Weyrich R, Zhang W, Sonderhouse L, Robinson JM, Ye J, Riehle F, Sterr U.

Phys Rev Lett. 2017 Jun 30;118(26):263202. doi: 10.1103/PhysRevLett.118.263202. Epub 2017 Jun 28.

PMID:
28707932
35.

Outcomes of robot-assisted simple enucleation of renal masses: A single European center experience.

Matei DV, Vartolomei MD, Musi G, Renne G, Tringali VML, Mistretta FA, Delor M, Russo A, Cioffi A, Bianchi R, Cozzi G, Di Trapani E, Bottero D, Cordima G, Lucarelli G, Ferro M, de Cobelli O.

Medicine (Baltimore). 2017 May;96(18):e6771. doi: 10.1097/MD.0000000000006771.

36.

The hunt for elusive cancer stem cells.

Condello S, Nwani NG, Matei D.

Oncotarget. 2017 Jun 13;8(24):38076-38077. doi: 10.18632/oncotarget.17443. No abstract available.

37.

VKORC1-1639 G>A Polymorphism and the Risk of Non-Variceal Upper Gastrointestinal Bleeding.

Groza I, Matei D, Tantau M, Trifa AP, Crisan S, Vesa SC, Bocsan C, Buzoianu AD, Acalovschi M.

J Gastrointestin Liver Dis. 2017 Mar;26(1):13-18. doi: 10.15403/jgld.2014.1121.261.vko.

38.

Biodynamic imaging for phenotypic profiling of three-dimensional tissue culture.

Sun H, Merrill D, An R, Turek J, Matei D, Nolte DD.

J Biomed Opt. 2017 Jan 1;22(1):16007. doi: 10.1117/1.JBO.22.1.016007.

39.

Reliability of Frozen Section Examination in a Large Cohort of Testicular Masses: What Did We Learn?

Matei DV, Vartolomei MD, Renne G, Tringali VML, Russo A, Bianchi R, Cozzi G, Bottero D, Musi G, Mazzarol G, Ferro M, de Cobelli O.

Clin Genitourin Cancer. 2017 Aug;15(4):e689-e696. doi: 10.1016/j.clgc.2017.01.012. Epub 2017 Feb 1.

PMID:
28216275
40.

Salvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph Nodes.

Jereczek-Fossa BA, Fanetti G, Fodor C, Ciardo D, Santoro L, Francia CM, Muto M, Surgo A, Zerini D, Marvaso G, Timon G, Romanelli P, Rondi E, Comi S, Cattani F, Golino F, Mazza S, Matei DV, Ferro M, Musi G, Nolè F, de Cobelli O, Ost P, Orecchia R.

Clin Genitourin Cancer. 2017 Aug;15(4):e623-e632. doi: 10.1016/j.clgc.2017.01.004. Epub 2017 Jan 11.

PMID:
28185875
41.

Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells.

Li J, Condello S, Thomes-Pepin J, Ma X, Xia Y, Hurley TD, Matei D, Cheng JX.

Cell Stem Cell. 2017 Mar 2;20(3):303-314.e5. doi: 10.1016/j.stem.2016.11.004. Epub 2016 Dec 29.

42.

Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer.

Ledermann JA, Harter P, Gourley C, Friedlander M, Vergote I, Rustin G, Scott C, Meier W, Shapira-Frommer R, Safra T, Matei D, Fielding A, Bennett B, Parry D, Spencer S, Mann H, Matulonis U.

Br J Cancer. 2016 Nov 22;115(11):1313-1320. doi: 10.1038/bjc.2016.348. Epub 2016 Nov 8.

43.

Complete Transcriptome RNA-Seq.

Miller DF, Yan P, Fang F, Buechlein A, Kroll K, Frankhouser D, Stump C, Stump P, Ford JB, Tang H, Michaels S, Matei D, Huang TH, Chien J, Liu Y, Rusch DB, Nephew KP.

Methods Mol Biol. 2017;1513:141-162.

PMID:
27807835
44.

Virtue male sling for post-prostatectomy stress incontinence: a prospective evaluation and mid-term outcomes.

Ferro M, Bottero D, D'Elia C, Matei DV, Cioffi A, Cozzi G, Serino A, Cordima G, Bianchi R, Incarbone PG, Brescia A, Musi G, Fusco F, Detti S, Mirone V, de Cobelli O.

BJU Int. 2017 Mar;119(3):482-488. doi: 10.1111/bju.13672. Epub 2016 Nov 1.

45.

Tissue Transglutaminase Activates Cancer-Associated Fibroblasts and Contributes to Gemcitabine Resistance in Pancreatic Cancer.

Lee J, Yakubov B, Ivan C, Jones DR, Caperell-Grant A, Fishel M, Cardenas H, Matei D.

Neoplasia. 2016 Nov;18(11):689-698. doi: 10.1016/j.neo.2016.09.003. Epub 2016 Oct 25.

46.

Multiparametric magnetic resonance imaging and frozen-section analysis efficiently predict upgrading, upstaging, and extraprostatic extension in patients undergoing nerve-sparing robotic-assisted radical prostatectomy.

Bianchi R, Cozzi G, Petralia G, Alessi S, Renne G, Bottero D, Brescia A, Cioffi A, Cordima G, Ferro M, Matei DV, Mazzoleni F, Musi G, Mistretta FA, Serino A, Tringali VM, Coman I, De Cobelli O.

Medicine (Baltimore). 2016 Oct;95(40):e4519.

47.

Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial.

Ledermann JA, Harter P, Gourley C, Friedlander M, Vergote I, Rustin G, Scott C, Meier W, Shapira-Frommer R, Safra T, Matei D, Fielding A, Spencer S, Rowe P, Lowe E, Hodgson D, Sovak MA, Matulonis U.

Lancet Oncol. 2016 Nov;17(11):1579-1589. doi: 10.1016/S1470-2045(16)30376-X. Epub 2016 Sep 9.

PMID:
27617661
48.

EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells.

Cardenas H, Zhao J, Vieth E, Nephew KP, Matei D.

Oncotarget. 2016 Dec 20;7(51):84453-84467. doi: 10.18632/oncotarget.11497.

49.

Bladder preservation in non-metastatic muscle-invasive bladder cancer (MIBC): a single-institution experience.

Gerardi MA, Jereczek-Fossa BA, Zerini D, Surgo A, Dicuonzo S, Spoto R, Fodor C, Verri E, Rocca MC, Nolè F, Muto M, Ferro M, Musi G, Bottero D, Matei DV, De Cobelli O, Orecchia R.

Ecancermedicalscience. 2016 Jul 14;10:657. doi: 10.3332/ecancer.2016.657. eCollection 2016.

50.

Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer.

de Leon M, Cardenas H, Vieth E, Emerson R, Segar M, Liu Y, Nephew K, Matei D.

Gynecol Oncol. 2016 Sep;142(3):539-47. doi: 10.1016/j.ygyno.2016.06.017. Epub 2016 Jun 30.

Supplemental Content

Support Center